Xenetic Biosciences (NASDAQ:XBIO) Stock Sees High Volatility: How to Trade Now?
Biopharmaceutical company, Xenetic Biosciences (NASDAQ:XBIO), on July 31, 2021 closure of previously announced private placement. This would be with single healthcare-focused institutional investor for 4,629,630 shares of the common stock. Xenetic focuses on a personalized CAR T platform technology for targeting patient and tumor specific neoantigens. The proceeds will be about $12.5 million before deducting placement agent fees and other offering expenses.The company issued to investor warrants for buying 4,629,630…